Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

Columbia University, New York

University of Pennsylvania, Philadelphia

University of Virginia Adult Neurology, Charlottesville

Virginia Commonwealth University, Richmond

UNC Department of Neurology, Chapel Hill

Charter Research, Lady Lake

Charter Research, Winter Park

University of Miami Miller School of Medicine Comprehensive Center for Brain Health, Boca Raton

JEM Research Institute, Atlantis

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

Renstar Medical Research, Ocala

University of Kentucky, Lexington

Ohio State University, Columbus

Cleveland Clinic Main Campus, Cleveland

IU Health Neuroscience Center, Goodman Hall, Indianapolis

Josephson Wallack Munshower Neurology, P.C, Indianapolis

Mayo Clinic, Rochester

Rush University Medical Center Section of Parkinson Disease and Movement Disorder, Chicago

The University of Kansas Alzheimer's Disease Research Center, Fairway

University of Texas Southwestern, Dallas

Clinical Trial Network, Houston

University of Colorado, Aurora

CenExel Rocky Mountain Clinical Research, LLC, Englewood

Barrow Neurological Institute, Phoenix

Banner Sun Health Research Institute, Sun City

University of Arizona - Health Sciences Center, Tucson

Pacific Neuroscience Institute, Santa Monica

Stanford University, Palo Alto

Summit Headlands, LLC, Portland

Oregon Health and Science University, Portland

Evergreen Health Research, Kirkland

Universtiy of Washington Department of Neurology, Seattle

New England Institute for Neurology and Headache (NEINH), Stamford

Headlands Research Eastern Massachusetts, LLC, Plymouth